X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (1077) 1077
Journal Article (875) 875
Conference Proceeding (25) 25
Publication (24) 24
Book Chapter (6) 6
Book / eBook (4) 4
Dissertation (3) 3
Report (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (349) 349
metallurgy (342) 342
physics (306) 306
blasting (246) 246
heating (246) 246
lighting (246) 246
mechanical engineering (246) 246
weapons (246) 246
electricity (232) 232
performing operations (230) 230
transporting (230) 230
humans (192) 192
optics (155) 155
basic electric elements (140) 140
devices or arrangements, the optical operation of which ismodified by changing the optical properties of the medium of thedevices or arrangements for the control of the intensity,colour, phase, polarisation or direction of light, e.g.switching, gating, modulating or demodulating (139) 139
frequency-changing (139) 139
male (139) 139
non-linear optics (139) 139
optical analogue/digital converters (139) 139
optical logic elements (139) 139
techniques or procedures for the operation thereof (139) 139
index medicus (135) 135
female (126) 126
advertising (116) 116
cryptography (116) 116
display (116) 116
education (116) 116
seals (116) 116
positive displacement machines for liquids (115) 115
pumps for liquids or elastic fluids (115) 115
animals (112) 112
rotary-piston, or oscillating-piston, positive-displacementmachines for liquids (110) 110
rotary-piston, or oscillating-piston, positive-displacementpumps (110) 110
human necessities (109) 109
engine plants in general (100) 100
machines or engines in general (100) 100
steam engines (100) 100
general tagging of cross-sectional technologies spanning over several sections of the ipc (98) 98
general tagging of new technological developments (98) 98
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (98) 98
calculating (92) 92
computing (92) 92
counting (92) 92
electric solid state devices not otherwise provided for (91) 91
glass (91) 91
middle aged (91) 91
mineral or slag wool (91) 91
semiconductor devices (91) 91
optical elements, systems, or apparatus (87) 87
microbiology (82) 82
displaying (79) 79
labels or name-plates (79) 79
signs (79) 79
hygiene (77) 77
medical or veterinary science (77) 77
aged (76) 76
electric communication technique (74) 74
adult (72) 72
electric digital data processing (71) 71
biochemistry (70) 70
enzymology (68) 68
technologies or applications for mitigation or adaptation againstclimate change (68) 68
beer (66) 66
devices using stimulated emission (66) 66
mutation or genetic engineering (66) 66
spirits (66) 66
vinegar (66) 66
wine (66) 66
organic chemistry (64) 64
culture media (58) 58
engineering elements and units (58) 58
general measures for producing and maintaining effectivefunctioning of machines or installations (58) 58
thermal insulation in general (58) 58
manufacture, shaping, or supplementary processes (57) 57
fixed constructions (56) 56
compositions thereof (55) 55
microorganisms or enzymes (55) 55
propagating, preserving or maintaining microorganisms (55) 55
transmission of digital information, e.g. telegraphiccommunication (53) 53
rotary-piston or oscillating-piston machines or engines (52) 52
processes using microorganisms (51) 51
vehicles in general (50) 50
preparations for medical, dental, or toilet purposes (49) 49
artificial stone (48) 48
cements (48) 48
ceramics (48) 48
compositions thereof, e.g. mortars, concrete or like buildingmaterials (48) 48
concrete (48) 48
lime, magnesia (48) 48
refractories (48) 48
slag (48) 48
treatment of natural stone (48) 48
adhesives (44) 44
dyes (44) 44
miscellaneous applications of materials (44) 44
miscellaneous compositions (44) 44
natural resins (44) 44
paints (44) 44
polishes (44) 44
specific therapeutic activity of chemical compounds ormedicinal preparations (43) 43
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1904) 1904
Japanese (217) 217
French (185) 185
German (132) 132
Chinese (74) 74
Korean (19) 19
Portuguese (3) 3
Italian (2) 2
Spanish (2) 2
Danish (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1979, 238
Book
Gastric Cancer, ISSN 1436-3291, 7/2016, Volume 19, Issue 3, pp. 919 - 926
Journal Article
Gastric Cancer, ISSN 1436-3291, 7/2017, Volume 20, Issue 4, pp. 640 - 645
Journal Article
Angewandte Chemie International Edition, ISSN 1433-7851, 01/2020
Journal Article
International Journal of Clinical Oncology, ISSN 1341-9625, 8/2016, Volume 21, Issue 4, pp. 668 - 675
Journal Article
Cancer Science, ISSN 1347-9032, 09/2019, Volume 110, Issue 9, pp. 2875 - 2883
Previous studies have shown sex‐related differences in the incidence of adverse events following treatment with fluoropyrimidines, however the mechanism of... 
S‐1 | oxaliplatin | fluorouracil | gastric cancer | sex | Thrombocytopenia - epidemiology | Neutropenia - epidemiology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Nausea - chemically induced | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Stomach Neoplasms - pathology | Oxaliplatin - adverse effects | Nausea - epidemiology | Cisplatin - administration & dosage | Incidence | Dose-Response Relationship, Drug | Female | Stomatitis - epidemiology | Oxaliplatin - administration & dosage | Neutropenia - chemically induced | Tegafur - adverse effects | Thrombocytopenia - chemically induced | Oxonic Acid - administration & dosage | Stomach Neoplasms - drug therapy | Oxonic Acid - adverse effects | Disease-Free Survival | Vomiting - chemically induced | Stomach Neoplasms - blood | Stomatitis - chemically induced | Sex Factors | Cisplatin - adverse effects | Tegafur - administration & dosage | Aged | Vomiting - epidemiology | Drug Combinations | DIHYDROPYRIMIDINE DEHYDROGENASE | TOXICITY | CHEMOTHERAPY | TRIAL | 5-FLUOROURACIL | CYP2A6 | THERAPY | PLASMA | ONCOLOGY | S-1 | JAPANESE | Antimitotic agents | Care and treatment | Cancer patients | Safety and security measures | Metastasis | Antineoplastic agents | Health aspects | Stomach cancer | Cancer | Thrombocytopenia | Enzymes | Leukopenia | Research funding | Diarrhea | Sex differences | Gender differences | Nausea | Cancer therapies | Cisplatin | Metastases | Studies | Body mass index | Stomatitis | Chemotherapy | Oxaliplatin | Vomiting | Medical prognosis | Gastric cancer | Potassium | Neutropenia | Pharmaceuticals | Original
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2013, Volume 31, Issue 35, pp. 4438 - 4444
Journal Article
Gastric Cancer, ISSN 1436-3291, 1/2019, Volume 22, Issue 1, pp. 138 - 146
Journal Article
Gastric Cancer, ISSN 1436-3291, 3/2019, Volume 22, Issue 2, pp. 344 - 354
Journal Article
Cancer Science, ISSN 1347-9032, 12/2016, Volume 107, Issue 12, pp. 1843 - 1850
This randomized phase II trial compared panitumumab plus fluorouracil, leucovorin, and irinotecan (FOLFIRI) with bevacizumab plus FOLFIRI as second‐line... 
colorectal cancer | RAS mutation | panitumumab | liquid biopsy | Bevacizumab | 1ST-LINE TREATMENT | LEUCOVORIN | MULTICENTER | DETERMINANTS | PHASE-III | ACQUIRED-RESISTANCE | FLUOROURACIL | TRIAL | CETUXIMAB | ONCOLOGY | 2ND-LINE TREATMENT | ras Proteins - genetics | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Biomarkers, Tumor | Fluorouracil - therapeutic use | Neoplasm Metastasis | Leucovorin - adverse effects | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Leucovorin - therapeutic use | Proto-Oncogene Proteins B-raf | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Bevacizumab - administration & dosage | Camptothecin - therapeutic use | Kaplan-Meier Estimate | Treatment Outcome | Retreatment | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Alleles | Aged | Mutation | Antimitotic agents | Chemotherapy | Endothelial growth factors | Analysis | Oncology, Experimental | Colorectal cancer | Clinical trials | Metastasis | Research | Antineoplastic agents | Blood proteins | Cancer | Immunoassay | Colorectal carcinoma | Values | Oncology | Serum proteins | Cancer therapies | K-Ras protein | Metastases | Proteins | Oxaliplatin | Epidermal growth factor | Vascular endothelial growth factor | Deoxyribonucleic acid--DNA | Immunoglobulins | Survival | Patients | Studies | Irinotecan | Biomarkers | Ligands | Original
Journal Article